Protein ZMYND8 tied to suppression of prostate cancer tumor metastasis
Although it reads like European license plate number, a protein known as ZMYND8 has demonstrated its ability to block metastasis-linked genes in prostate cancer, according to a study at The University of Texas MD Anderson Cancer Center. The findings, resulting from cell line and mouse model studies, are published in the July 28 online issue of Molecular Cell.
“These findings are important as cancer metastasis is a complicated...
Genetic cause of 15 percent of colorectal cancer diagnoses identified
Up to 15 percent of colorectal cancers show a genetic mutation known as DNA mismatch repair deficiency, or dMMR. Until now, little has been...
MD Anderson, NASA and ILC Dover partner on Space Suit Art Project to increase childhood cancer awareness
Today, several of Space City’s best-known institutions — The University of Texas MD Anderson Cancer Center, the National Aeronautics and Space...